HDAC2 regulates FoxO1 during RANKL-induced osteoclastogenesis

Area of Science:

• Cell Biology
• Bone Biology
• Molecular Biology

Background:

• Osteoclasts (OCs) are crucial for bone homeostasis.
• Dysregulated osteoclast activity contributes to bone diseases like osteoporosis.

Purpose of the Study:

• To investigate the role of histone deacetylase 2 (HDAC2) in osteoclastogenesis.
• To elucidate the molecular mechanism by which HDAC2 regulates osteoclast differentiation and function.

Main Methods:

• Examined HDAC2 expression in bone marrow macrophages (BMMs) during osteoclastogenesis.
• Utilized lentivirus infection for HDAC2 overexpression and deletion in BMMs.
• Assessed osteoclastogenesis and bone resorption assays.
• Investigated the signaling pathway involving Akt and Forkhead box protein O1 (FoxO1).

Main Results:

• HDAC2 expression increased during RANKL-induced osteoclastogenesis.
• HDAC2 overexpression enhanced, while HDAC2 deletion suppressed osteoclastogenesis and bone resorption.
• HDAC2 activation of Akt led to phosphorylation and inactivation of FoxO1, a negative regulator.
• HDAC2 deletion resulted in decreased Akt activation and increased FoxO1 activity.

Conclusions:

• HDAC2 acts as a key positive regulator in RANKL-induced osteoclastogenesis.
• The HDAC2-Akt-FoxO1 pathway is critical for controlling osteoclast differentiation and bone resorption.
• HDAC2 presents a potential therapeutic target for modulating osteoclast activity in bone diseases.